Helicobacter pylori urease, protease, and phospholipase enzymes

Helicobacter pylori urease, protease, and phospholipase enzymes are a group of virulence factors essential for the survival and pathogenicity of H. pylori in the human stomach. Urease is a high-expression enzyme that converts urea into ammonia and carbon dioxide, effectively neutralizing the surrounding gastric acid to facilitate colonization (Source: NIH, StatPearls). Proteases and phospholipases work synergistically to degrade the protective mucus layer and host cell membranes, promoting inflammation and ulcer formation (Source: PubMed, PMID: 11591062). These enzymes are critical for the development of chronic gastritis, peptic ulcers, and are linked to an increased risk of gastric cancer. While urease is a primary diagnostic target via the urea breath test, these enzymes also represent potential therapeutic targets to disrupt bacterial fitness. Current treatment strategies typically involve a combination of antibiotics and proton pump inhibitors to eradicate the infection and mitigate the damage caused by these enzymatic activities. Inhibition of these enzymes can prevent the bacteria from establishing a niche and damaging the gastric epithelium.

Other names

H. pylori virulence enzymesUreaseProteasePhospholipase

Urease inhibitors like acetohydroxamic acid block the conversion of urea to ammonia, preventing the bacteria from neutralizing stomach acid and surviving (Source: PubMed, PMID: 25506050). Protease and phospholipase inhibitors, though less common clinically, aim to prevent the degradation of the gastric mucosal barrier and host cell membranes (Source: PubMed, PMID: 11591062).